Adjuvant nivolumab vs placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
  • Galsky, M. D.
  • Gschwend, J.
  • Milowsky, M.
  • Schenker, M.
  • Valderrama, B. Perez
  • 외 15명
Citations

WEB OF SCIENCE

2
제목
Adjuvant nivolumab vs placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
저자
Galsky, M. D.Gschwend, J.Milowsky, M.Schenker, M.Valderrama, B. PerezTomita, Y.Bamias, A.Lebret, T.Shariat, S. F.Park, S. H.Agerbaek, M.Jha, G.Stenner-Liewen, F.Ye, D.Giudici, F.Connors, J.Gupta, S.Zhang, J.Bajorin, D.Witjes, J. A.
DOI
10.1016/j.annonc.2025.08.3682
발행일
2025-09
유형
Meeting Abstract
저널명
Annals of Oncology
36